Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ZOETIS INC
04/14 ZOETIS : to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therap..
04/13 ZOETIS : to Acquire Nexvet for US$6.72 in Cash Per Share
04/13 ZOETIS : to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therap..
04/05 ZOETIS : Nick Lachey Encourages Dog Owners to Test Their Animal Instincts to Hel..
04/04 OUR RESPONSIBILITIES TO SOCIETY : A Closer Look at How Zoetis Advances Animal He..
03/31 ZOETIS : to Host Webcast and Conference Call on First Quarter 2017 Financial Res..
03/21 ZOETIS : to Participate in the Jefferies Animal Health Summit
03/06 ZOETIS : Expands K-9 Courage™ Program to Support Service Dogs Assisting Ve..
02/17 ZOETIS : Statement on the Positive Opinion for Cytopoint Adopted by the European..
02/17 ZOETIS : to Participate in the Cowen and Company 37th Annual Health Care Confere..
02/16DJZOETIS : Dims Outlook
02/16 ZOETIS : tops 4Q profit forecasts
02/16 ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
02/15 ZOETIS : Receives European Commission Approval for Stronghold® Plus
02/15 ZOETIS INC. (NYSE : ZTS) Files An 8-K Regulation FD Disclosure
More most relevant news
All news about ZOETIS INC
04/14 ZOETIS : to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therap..
04/13 ZOETIS : to Acquire Nexvet for US$6.72 in Cash Per Share
04/13 ZOETIS : to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therap..
04/07 ZOETIS : Studies from Zoetis Inc. Yield New Information about Bradykinin (Pharma..
04/06 ZOETIS : Studies from Zoetis Inc. Yield New Information about Bradykinin (Pharma..
04/05 ZOETIS : Nick Lachey Encourages Dog Owners to Test Their Animal Instincts to Hel..
04/04 OUR RESPONSIBILITIES TO SOCIETY : A Closer Look at How Zoetis Advances Animal He..
03/31 ZOETIS : to Host Webcast and Conference Call on First Quarter 2017 Financial Res..
03/30 ZOETIS : to Participate in the Jefferies Animal Health Summit
03/21 ZOETIS : to Participate in the Jefferies Animal Health Summit
More news
Sector news : Veterinary Drugs
04/25DJSHIRE : Files 8K - Other Events
04/25DJSHIRE : Files 8K - Changes To Articles
04/25DJNasdaq Composite Tops 6000 for First Time
04/25DJASTRAZENECA : Lung Cancer Treatment Approved in EU
04/25DJELI LILLY AND : Working to Cut Costs
04/25 Fresenius picks up M&A pace with Akorn, Merck KGaA deals
More sector news : Veterinary Drugs
News from SeekingAlpha
04/17 Zoetis To Acquire Nexvet Biopharma For Animal Pain Management
04/13 RISK ARBITRAGE TODAY : Could Apple Really Buy Disney?
04/13 Nexvet Bio up big on $85M bid from Zoetis
04/10 GOLDMAN : 21 stocks seen lifting margins
03/30 Schlumberger Is A Buy - Cramer's Lightning Round (3/29/2017)
03/20 ACKMAN'S PERSHING SQUARE :   The Death Spiral Is Accelerating
Latest Tweets
04/25Zoetis Inc $ZTS Shares Sold by Diversified Trust Co  
04/245 Trade Ideas for Monday: $AEP $HD $ORCL $PPG $ZTS
1
04/23Dragonfly Capital - 5 Trade Ideas for Monday: $AEP $HD $ORCL $PPG $ZTS
1
04/235 Trade Ideas for Monday: American Electric Power, Home Depot, Oracle, PPG an.. 
04/18CENTRAL TRUST Co Has $142,000 Stake in Zoetis Inc $ZTS  
More tweets
Qtime:63
Advertisement
Financials ($)
Sales 2017 5 172 M
EBIT 2017 1 788 M
Net income 2017 1 095 M
Debt 2017 2 579 M
Yield 2017 0,77%
P/E ratio 2017 25,24
P/E ratio 2018 21,20
EV / Sales 2017 5,73x
EV / Sales 2018 5,35x
Capitalization 27 035 M
More Financials
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Full-screen chart
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 59,5 $
Spread / Average Target 8,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC2.73%27 035
JINYU BIO-TECHNOLOGY C..49.34%3 021
DECHRA PHARMACEUTICALS..21.04%1 940
VIRBAC-18.42%1 254
PULIKE BIOLOGICAL ENGI..5.75%1 205
PHIBRO ANIMAL HEALTH C..-3.41%1 121
More Results